The Australian Patent Office has granted us a second patent on Prorox® due to the uniqueness of the formulation. The patent is for the Prevention or Treatment of Benign Prostatic Hyperplasia (BPH) and Related Disorders. We have multiple bladder and prostate patent families, and Urox is currently patented or patent-pending in 25 countries with numerous global trademarks.
- A new article on the success of our children’s bedwetting formula has just been published in NutraIngredients USA
- Our bedwetting research has just been published in Phytomedicine Journal!
- Seipel Group to present and lead roundtable discussion at the Naturally Informed virtual event Mastering the Market: Healthy Ageing.
- New article by Tracey Seipel in Wholefoods Magazine, USA. Bladder Control Significant Yet Underserved Supplement Category for Healthy Aging
- Urox® has just been announced as a finalist in the Asia Eldercare Awards for Innovation of the Year: Product.